Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Fanxing Xu is active.

Publication


Featured researches published by Fanxing Xu.


Neurosignals | 1995

Effects of Melatonin on Hypothalamic γ-Aminobutyric Acid, Aspartic Acid, Glutamic Acid, β-Endorphin and Serotonin Levels in Male Mice

Fanxing Xu; Li J; K.C. Ma; Mingying Wang

Effects of melatonin on hypothalamic neurotransmitters in male mice were studied. Exogenous melatonin administered intraperitoneally significantly increased (p


Bioorganic & Medicinal Chemistry Letters | 2017

Design and synthesis of novel nitrogen mustard-evodiamine hybrids with selective antiproliferative activity

Xu Hu; Yan Wang; Jingjing Xue; Tong Han; Runwei Jiao; Zhan-Lin Li; Weiwei Liu; Fanxing Xu; Hui-Ming Hua; Dahong Li

A series of novel nitrogen mustard-evodiamine hybrids were synthesized and evaluated for their antitproliferative properties. The antiproliferative activities of 10a-d, 11a-d, and 12a-d against four different kinds of human cancer cell lines (PC-3, HepG2, THP-1 and HL-60) and human normal peripheral blood mononuclear cells (PBMC) were determined. The results showed that all the target hybrid compounds exhibited antiproliferative activities against tested human tumor cell lines to some extent and no antiproliferative activities (>200 μM) against human normal PBMC cells. The antiproliferative selectivity between tumorous and normal cells was very useful for further antitumor drug development. Among the target compounds, 12c showed the strongest cytotoxicity against two tumor cell lines (THP-1 and HL-60) with IC50 values of 4.05 μM and 0.50 μM, respectively, and selected for further mechanism study in HL-60 cells. The results showed that 12c could induce HL-60 cells apoptosis and arrest at G2 phase at low sub-micromolar concentrations via mitochondria-related pathways.


Fitoterapia | 2017

New amides from seeds of Silybum marianum with potential antioxidant and antidiabetic activities

Ningbo Qin; Cui-Cui Jia; Jun Xu; Dahong Li; Fanxing Xu; Jiao Bai; Zhan-Lin Li; Hui-Ming Hua

Two new amide compounds, mariamides A and B (1-2), were obtained together with fourteen known compounds from the seeds of milk thistle (Silybum marianum). Their structures were established on the basis of extensive 1D and 2D NMR analyses, as well as HR-ESI-MS data. Most of the compounds showed significant antioxidant activities than positive control in ABTS and FRAP assays. However, only amide compounds 1-4 showed moderate DPPH radical scavenging activity and compounds 7 and 16 showed the most potent activity against DPPH. Most of the compounds showed moderate to stronger α-glucosidase inhibitory activities. Nevertheless, only flavonoids showed strong PTP1B inhibitory activities. These results indicate a use of milk thistle seed extracts as promising antioxidant and antidiabetic agents.


European Journal of Medicinal Chemistry | 2018

Novel hybrids of brefeldin A and nitrogen mustards with improved antiproliferative selectivity: Design, synthesis and antitumor biological evaluation

Tong Han; Kangtao Tian; Huaqi Pan; Yongxiang Liu; Fanxing Xu; Zhan-Lin Li; Takahiro Uchita; Ming Gao; Hui-Ming Hua; Dahong Li

A series of novel conjugates of brefeldin A (11a-c, 12a-c and 13a-c) were obtained by introducing a variety of nitrogen mustards at 4-OH or 7-OH position to explore more efficacious and less toxic antitumor agents. The antiproliferative activities were tested against three cancer cell lines (HL-60, PC-3 and Bel-7402) and one multidrug resistant cell line Bel-7402/5-FU. Among them, compound 11a was the strongest derivative with IC50 values of 4.48, 9.37, 0.2 and 0.84 μM, respectively, and more potent than nitrogen mustards. Though the antiproliferative potency was weaker than the lead compound brefeldin A, 11a displayed lower toxicity than brefeldin A (IC50 < 0.001 μM) with an IC50 of 9.74 μM against normal human liver L-O2 cells, showing good selectivity between normal and malignant liver cells. The mechanism studies confirmed that 11a could induce apoptosis, arrest cell cycle at the G1 phase and lead to mitochondrial dysfunction in Bel-7402 cells at submicromolar concentrations. Furthermore, 11a induced the intrinsic apoptotic mitochondrial pathway in Bel-7402 cells, evidenced by the enhanced expression of the pro-apoptotic protein Bax, cyto-c and p53, and the reduced expression of the anti-apoptotic protein Bcl-2. The caspase-9 and -3 levels were also up-regulated.


Biomedicine & Pharmacotherapy | 2018

Involvement of estrogen receptors in silibinin protection of pancreatic β-cells from TNFα- or IL-1β-induced cytotoxicity

Jing Yang; Yue Sun; Fanxing Xu; Weiwei Liu; Toshihiko Hayashi; Satoshi Onodera; Shin-ichi Tashiro; Takashi Ikejima

Silibinin is a polyphenolic flavonoid that exhibits anticarcinogenic, anti-inflammatory and cytoprotective effects. The effect of silibinin on pancreatic islet β-cell is yet largely unknown in spite of well documented-hepatoprotective effects. Protecting the functional insulin-producing β-cells in the pancreas is a major therapeutic challenge in the patients with type 1 (T1DM) or type 2 diabetes mellitus (T2DM). This study reports the effect of silibinin on the rat pancreatic β-cell line, INS-1, damaged with pro-inflammatory cytokine, TNFα or IL-1β. Exposure to TNFα or IL-1β for 48 h caused INS-1 cells to reduce the production of insulin as well as cell viability. These actions of TNFα or IL-1β are associated with suppression of the expression of estrogen receptors (ERs). Further study revealed that silibinin protected the suppression in the expression of both ERα and ERβ that were involved in insulin synthesis and release, respectively. Furthermore, evidence is obtained that silibinin may impede the loss of critical INS-1 cells by promoting autophagy and preventing apoptosis. Direct cytoprotective effects of silibinin on INS-1 cells suggest that silibinin may be therapeutically beneficial for diabetes.


Bioorganic Chemistry | 2019

Hydrogen sulfide releasing enmein-type diterpenoid derivatives as apoptosis inducers through mitochondria-related pathways

Fanxing Xu; Xiang Gao; Haonan Li; Shengtao Xu; Xu Li; Xu Hu; Zhan-Lin Li; Jinyi Xu; Hui-Ming Hua; Dahong Li

In this study, we combined two enemin-type diterpenoid derivatives with two well-established hydrogen sulfide moieties via ester or different anhydride linkers, to search apoptosis inducing drug candidate capable of hydrogen sulfide generating. Therefore, a series of hybrids were synthesized and superior antiproliferative efficacy accompanied with enhanced selectivity was observed under extensive pharmacological evaluations. A standard methylene blue (MB+) method was applied to measure the capacity for the hydrogen sulfide generation of all the target derivatives. One particular molecule A1, which contained α-thioctic acid moiety for hydrogen sulfide donating, manifested more potent antiproliferative activity. It exerted inhibitory effects against Bel-7402, SGC-7901 and A549 cell lines with IC50 values of 2.16, 5.07 and 6.98 μM respectively. While it exacted relatively low effects over human normal cell lines L-02 and PBMC with IC50 values of 15.81 μM for the prior and 14.15 μM for the latter, and displayed better selectivity index (SI) than parent diterpenoids. A high dosage of H2S release was also recorded. Hence, A1 was most suitable for mechanistic exploration on account of both safety and efficacy. The ensuing biological assays revealed central role of apoptosis in A1s mode of action for antiproliferative efficacy, which led to further confirmation of G1 phase cell cycle arrest, mitochondria membrane potential collapse and apoptotic activation in Bel-7402 cells. Further western blot assay on intrinsic mitochondria pathway unlocked intricate interplay among a series of apoptotic related proteins in which Bax, caspase-3 and cytochrome c went through up-regulation, while Bcl-2, Bcl-xL and procaspase-3 undergone down-regulation. In a nutshell, a hydrogen sulfide releasing hybrid A1 was synthesized and antiproliferative evaluation identified it to be a worthy drug candidate for future in depth study.


European Journal of Medicinal Chemistry | 2018

Antiproliferative hydrogen sulfide releasing evodiamine derivatives and their apoptosis inducing properties

Xu Hu; Runwei Jiao; Haonan Li; Xianhua Wang; Haoda Lyu; Xiang Gao; Fanxing Xu; Zhan-Lin Li; Hui-Ming Hua; Dahong Li

To explore antitumor agents with high efficiency and selectivity, two series of 16 H2S donating evodiamine derivatives 8-12 were synthesized and characterized by 1H NMR, 13C NMR and HRMS. Their antiproliferative activities were tested against five cancer cell lines (Bel-7402, MCF-7, SGC-7901, Caco-2 and HL-60) and human normal peripheral blood mononuclear cells. Among them, compound 12c showed the most potent inhibitory activities against human leukemia HL-60 and epithelial colorectal adenocarcinoma Caco-2 cells with IC50 values of 0.58 and 2.02 μM, respectively. Additionally, high selectivity was also observed between human normal peripheral blood mononuclear cells and human leukemia HL-60 cells. Further mechanism studies confirmed that 12c could induce apoptosis, arrest cell cycle at the G2/M phase and lead to mitochondrial dysfunction in HL-60 cells. Furthermore, western blot assay demonstrated that 12c induced the intrinsic apoptotic mitochondrial pathway by upregulating protein expression of Bax, cytochrome c, caspase-3, -9 and p53, and downregulating the relative levels of Bcl-2. The levels of cell cycle related proteins cyclin B1 and cdc2 were also downregulated in which G2/M phase arrest was confirmed. Overall, 12c possessed immense potential for the discovery of antitumor candidates with high efficiency and selectivity.


European Journal of Medicinal Chemistry | 2017

Scutellarin derivatives as apoptosis inducers: Design, synthesis and biological evaluation

Tong Han; Jia Li; Jingjing Xue; He Li; Fanxing Xu; Keguang Cheng; Dahong Li; Zhan-Lin Li; Ming Gao; Hui-Ming Hua


European Journal of Medicinal Chemistry | 2017

Nitric oxide-releasing derivatives of brefeldin A as potent and highly selective anticancer agents

Kangtao Tian; Fanxing Xu; Xiang Gao; Tong Han; Jia Li; Huaqi Pan; Linghe Zang; Dahong Li; Zhan-Lin Li; Takahiro Uchita; Ming Gao; Hui-Ming Hua


Molecular and Cellular Biochemistry | 2018

Silibinin ameliorates amylin-induced pancreatic β-cell apoptosis partly via upregulation of GLP-1R/PKA pathway

Jing Yang; Yue Sun; Fanxing Xu; Weiwei Liu; Yingsi Mai; Toshihiko Hayashi; Shunji Hattori; Yuko Ushiki-Kaku; Satoshi Onodera; Shin-ichi Tashiro; Takashi Ikejima

Collaboration


Dive into the Fanxing Xu's collaboration.

Top Co-Authors

Avatar

Dahong Li

Shenyang Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Hui-Ming Hua

Shenyang Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Zhan-Lin Li

Shenyang Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Ming Gao

Mukogawa Women's University

View shared research outputs
Top Co-Authors

Avatar

Tong Han

Shenyang Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Xiang Gao

Shenyang Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Xu Hu

Shenyang Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Jia Li

Shenyang Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Jing Yang

Shenyang Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Takashi Ikejima

Shenyang Pharmaceutical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge